Evidence map›Paper›PMID 35758651›Full record

ArticleeLife2022

Cystathionine-β-synthase is essential for AKT-induced senescence and suppresses the development of gastric cancers with PI3K/AKT activation.

Haoran Zhu, Keefe T Chan, Xinran Huang, Carmelo Cerra, Shaun Blake, Anna S Trigos, Dovile Anderson, Darren J Creek, David P De Souza, Xi Wang and 5 more

Open access · goldAbstract read
In one paragraph

Article in eLife, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. New insights into the regulation ofFrontiers in neuroscience · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 2 countries.

Haoran Zhu *Division of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, Australia.
Keefe T Chan *Division of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, Australia.ORCID 0000-0001-6114-3724
Xinran HuangDivision of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, Australia.
Carmelo CerraDivision of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, Australia.
Shaun BlakeDivision of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, Australia.
Anna S TrigosDivision of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, Australia.ORCID 0000-0002-5915-2952
Dovile AndersonMonash Institute of Pharmaceutical Sciences, Victoria, Australia.
Darren J CreekMonash Institute of Pharmaceutical Sciences, Victoria, Australia.
David P De SouzaMetabolomics Australia, Bio21 Molecular Science and Biotechnology Institute, Victoria, Australia.
Xi WangDepartment of Oncology, The People's Liberation Army No. 903rd Hospital, Hangzhou, China.
Caiyun FuZhejiang Provincial Key Laboratory of Silkworm Bioreactor and Biomedicine, College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou, China.
Metta JanaDivision of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, Australia.
Elaine SanijDivision of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, Australia.
Richard B PearsonDivision of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, Australia.ORCID 0000-0001-5919-5090
Jian KangDivision of Cancer Research, Peter MacCallum Cancer Centre, Melbourne, Australia.ORCID 0000-0001-9998-4975
The University of Melbourne · AUPeter MacCallum Cancer Centre · AUZhejiang Sci-Tech University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hyperactivation of oncogenic pathways downstream of RAS and PI3K/AKT in normal cells induces a senescence-like phenotype that acts as a tumor-suppressive mechanism that must be overcome during transformation. We previously demonstrated that AKT-induced senescence (AIS) is associated with profound transcriptional and metabolic changes. Here, we demonstrate that human fibroblasts undergoing AIS display upregulated cystathionine-β-synthase (CBS) expression and enhanced uptake of exogenous cysteine, which lead to increased hydrogen sulfide (H

Indexed as

Hydrogen SulfideStomach NeoplasmsCystathionineCystathionine beta-SynthaseGlutathioneGlycogen SynthaseHumansPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktCystathionineCystathionine beta-SynthaseGlutathioneGlycogen SynthaseHydrogen SulfidePhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktcancer biologycell biologycystathionine-β-synthasegastric cancerglutathionehumanmouseoxidative stressPI3K/AKT signalingsenescence

Identifiers

PMID35758651
PMCPMC9236611
OpenAlexW4283585651

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.